Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)

SHA:688203 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	420.35	515.73	855.7	938.49	248.81	593.68
Trading Asset Securities	-	-	-	-	42.18	-
Cash & Short-Term Investments	420.35	515.73	855.7	938.49	290.98	593.68
Cash Growth	-17.94%	-39.73%	-8.82%	222.52%	-50.99%	782.45%
Accounts Receivable	95.28	69.91	36.77	12.94	4.89	4.38
Other Receivables	0.8	0.01	0.01	0.12	0.04	-
Receivables	96.08	69.92	36.77	13.06	4.93	4.38
Inventory	200.22	160.52	145.6	135.94	120.88	72.85
Other Current Assets	80.84	61.84	28.91	14.89	32.19	27.44
Total Current Assets	797.49	808.01	1,067	1,102	448.99	698.35
Property, Plant & Equipment	1,180	1,175	823.8	744.12	654.59	438.57
Other Intangible Assets	74.3	75.58	76.81	78.57	78.9	30.5
Long-Term Deferred Tax Assets	2.87	3.12	1.7	1.09	0.17	0.11
Other Long-Term Assets	3.78	4	81.22	2.33	0.63	-
Total Assets	2,058	2,066	2,051	1,928	1,183	1,168
Accounts Payable	262.85	158.56	175.89	80.34	24.78	108.96
Accrued Expenses	10.81	18.97	15.3	12.81	8.75	7.11
Short-Term Debt	153.72	93.54	74.4	40.37	170.01	112.86
Current Portion of Long-Term Debt	48.05	68.41	104.53	98.76	47.32	30.05
Current Portion of Leases	-	0.69	0.62	1.02	-	-
Current Income Taxes Payable	12.1	3.36	2.17	2.84	1.3	3.13
Current Unearned Revenue	10.54	9.49	12.46	3.25	9.53	6.92
Other Current Liabilities	16.02	128.43	53.78	67.99	98.54	135.82
Total Current Liabilities	514.09	481.45	439.15	307.37	360.24	404.86
Long-Term Debt	10.81	33.24	74	127.31	162.82	143.83
Long-Term Leases	2.82	3.38	4.3	4.92	6.07	-
Long-Term Unearned Revenue	57.14	55.38	51.1	36.09	0.1	0.07
Long-Term Deferred Tax Liabilities	0.51	0.6	0.71	0.87	0.03	-
Total Liabilities	585.38	574.05	569.25	476.56	529.26	548.76
Common Stock	202.68	202.68	202.68	202.68	152.01	152.01
Additional Paid-In Capital	1,209	1,209	1,209	1,209	509.1	509.74
Retained Earnings	81.41	88.59	69.3	39.94	-7.12	-42.39
Treasury Stock	-20.5	-9	-	-	-	-
Total Common Equity	1,473	1,492	1,481	1,452	653.99	619.36
Minority Interest	-	-	-	0.01	0.03	-0.59
Shareholders' Equity	1,473	1,492	1,481	1,452	654.02	618.77
Total Liabilities & Equity	2,058	2,066	2,051	1,928	1,183	1,168
Total Debt	215.4	199.26	257.84	272.37	386.22	286.74
Net Cash (Debt)	204.95	316.47	597.86	666.11	-95.24	306.94
Net Cash Growth	-37.52%	-47.07%	-10.25%	-	-	-
Net Cash Per Share	0.86	1.56	2.88	3.97	-0.62	3.33
Filing Date Shares Outstanding	332.86	201.42	202.68	202.68	152.01	152.01
Total Common Shares Outstanding	332.86	201.75	202.68	202.68	152.01	152.01
Working Capital	283.4	326.55	627.83	795	88.75	293.49
Book Value Per Share	4.42	7.39	7.31	7.16	4.30	4.07
Tangible Book Value	1,399	1,416	1,404	1,373	575.09	588.86
Tangible Book Value Per Share	4.20	7.02	6.93	6.78	3.78	3.87
Buildings	-	257.08	256.7	194.24	147.1	130.13
Machinery	-	542.28	529.31	350.52	331.11	258.05
Construction In Progress	-	603.78	201.89	310.49	248.24	93.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.